# The MASTER Study (MAmmary Cancer STatin ER Positive Study)

> **NCT04601116** · PHASE3 · RECRUITING · sponsor: **Aarhus University Hospital** · enrollment: 3360 (estimated)

## Conditions studied

- Breast Cancer Female
- Estrogen Receptor Positive Tumor

## Interventions

- **DRUG:** Atorvastatin 80 Mg Oral Tablet
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04601116
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-04
- **Primary completion:** 2025-01-01
- **Final completion:** 2035-01-01
- **Target enrollment:** 3360 (ESTIMATED)
- **Last updated:** 2021-01-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04601116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04601116, "The MASTER Study (MAmmary Cancer STatin ER Positive Study)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04601116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*